ALK inhibitor 2 25 mg | 99.00%
TargetMol
ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
More Information Supplier PageALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
More Information Supplier PageSRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageLiensinine is the active constituent of plumula nelambinis with anti-hypertension.
More Information Supplier PageLiensinine is the active constituent of plumula nelambinis with anti-hypertension.
More Information Supplier PagePF-06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
More Information Supplier PagePF-06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
More Information Supplier PageCDDO is a synthetic oleanane triterpenoid that blocks the cellular synthesis of inducible nitric oxide synthase and inducible COX-2 in INF-γ-activated mouse macrophages with an IC50 value of 0.4 nM. By suppressing reactive oxygen and nitrogen species (ROS/RNS) formation, it promotes the cellular control of ROS/RNS levels that would lead to DNA damage associated with […]
More Information Supplier Page